去甲斑蝥素对骨髓瘤U266细胞Notch信号通路表达的影响
Norcantharidin influences the expression of Notch signal pathway in multiple myeloma U226 cells

DOI: 10.6040/j.issn.1671-7554.0.2016.458

Keywords: 多发性骨髓瘤,U266细胞,去甲斑蝥素,Notch信号通路,细胞凋亡,
Multiple myeloma,Notch signal pathway,Norcantharidin,U266 cells,Apoptosis

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Lee JY, Song SY, Park JY. Notch pathway activation is associated with pancreatic cancer treatment failure[J]. Pancreatology, 2014, 14(1):48 -53.
[2]	张金巧, 戴晓丽,蒙艳凤, 等. 去甲斑蝥素对人多发性骨髓瘤细胞株U266生长调控的影响及其机制的研究[J]. 河北医科大学学报, 2010, 31(8): 896-897. ZHANG Jinqiao, DAI Xiaoli, MENG Yanfeng, et al. Effect of Norcantharidin of on the growth control of human myeloma cell line U266 and its mechanism[J]. Journal of Hebei Medical University, 2010, 31(8):896-897.
[3]	Xiong X, Wu M, Zhang H, et al. Atg5 siRNA inhibits autophagy and enhances norcantharidin-induced apoptosis in hepatocellular carcinoma[J]. Int J Oncol, 2015, 47(4):1321-1328.
[4]	李斑斑. 乏氧与 Notch1对人多发性骨髓瘤细胞增殖和凋亡的影响[D]. 泰安: 泰山医学院, 2014: 2-6.
[5]	杨春秀, 陈建斌, 张树君, 等. Notch2胞内段基因过表达对K562细胞增殖的影响及其机制[J]. 中国生物制品学杂志, 2011, 24(11):1278-1289. YANG Chunxiu, CHEN Jianbin, ZHANG Shujun, et al. Effect of Overexpression of Intracellular Domain of Notch2 Gene on Prolifera-tion of K562 Cells and Relevant Mechanism[J]. Chin J Biologicals, 2011, 24(11):1278-1289.
[6]	Ramakrishnan V, Ansell S, Haug J, et al. MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma[J]. Leukemia, 2012, 26(2):340-348.
[7]	Schwarzer R, Nicke N, Godau J, et al. Notch pathway inhibition controls myeloma bone disease in the murine MOPC315.BM model[J]. Blood Cancer Journal, 2014, 4(6):217.
[8]	Gopalakrishnan N, Saravanakumar M, Madankumar P, et al. Colocalization of β-catenin with Notch intracellular domain in colon cancer: a possible role of Notch1 signaling in activation of CyclinD1-mediated cell proliferation[J]. Mol Cell Biochem, 2014, 396(1-2):281-293.
[9]	Aster JC, Blacklow SC, Pear WS. Notch signaling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies[J]. J Pathol, 2011, 223(2): 262-273.
[10]	Li X, He X, Tian W, et al. Short hairpin RNA targeting Notch2 inhibits U87 human glioma cell proliferation by inducing cell cycle arrest and apoptosis in vitro and in vivo[J]. Mol Med Rep, 2014, 10(6):2843-2850.
[11]	Colombo M, Mirandola L, Platonova N, et al. Notch-directed microenvironment reprogramming in myeloma:a single path to multiple outcomes[J]. Leukemia, 2013, 27(5):1009-1018.
[12]	Xie J, Zhang Y, Hu X, et al. Norcantharidin inhibits Wnt signal pathway via promoter demethylation of WIF-1 in human non-small cell lung cancer[J]. Med Oncol, 2015, 32(5):145.
[13]	Zheng LC, Yang MD, Kuo CL, et al. Norcantharidin-induced apoptosis of AGS human gastric cancer cells through reactive oxygen species production, and caspase- and mitochondria-dependent signaling pathways[J]. Anticancer Res, 2016, 36(11): 6031-6042.
[14]	Guo D, Li C, Teng Q, et al. Notch1 overexpression promotes cell growth and tumor angiogenesis in myeloma[J]. Neoplasma, 2013, 60(1): 33-40.
[15]	卢燕燕, 肖翠容, 陈华英, 等. 阿霉素诱导的骨髓瘤细胞化疗耐药的分子机制分析[J]. 中国实验血液学杂志, 2014, 22(5): 1336-1340. LU Yanyan, XIAO Cuirong, CHEN Huaying, et al. Molecular mechanism of Doxorubicin resistance in multiple myeloma cell line[J]. Journal of Experimental Hematology, 2014, 22(5): 1336-1340.
[16]	Xu D, Hu J, De Bruyne E, et al. Dll1/Notch activation contributes to bortezomib resistance by upregulating CYP1A1 in multiple myeloma[J]. Biochem Biophys Res Commun, 2012, 428(4):518-524.
[17]	Yao J, Zheng K, Li C, et al. Interference of Notch1 inhibits the growth of glioma cancer cells by inducing cell autophagy and down-regulation of Notch1-Hes-1 signaling pathway[J]. Med Oncol, 2015, 32(6):174-181.
[18]	Zhang W, Nie Y, Chong L, et al. PI3K and Notch signal pathways coordinately regulate the activation and proliferation of T lymphocytes in asthma[J]. Life Sci, 2013, 92(17-19):890-895.
[19]	Ke X, Zhao Y, Lu X, et al. TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling[J]. Oncotarget, 2014, 6(32): 32610-32612.
[20]	Cialfi S, Palermo R, Manca S, et al. Loss of Notch1-dependent p21(Waf1/Cip1)expression influences the Notch1 outcome in tumorigenesis[J]. Cell Cycle, 2014, 13(13):2046-2055.
[21]	Cornils H, Kohler RS, Hergovich A, et al. Human NDR kinases control G1/S Cell Cycle transition by directly regulating p21 stability[J]. Mol Cell Biol, 2011, 31(7): 1382-1395.

Full-Text